Wed, March 20, 2024

Silvan Tuerkcan Reiterated (TSHA) at Buy and Held Target at $5 on, Mar 20th, 2024

Silvan Tuerkcan of JMP Securities, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Buy and Held Target at $5 on, Mar 20th, 2024.

Silvan, nor any peers, have made any analyst calls on TSHA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30